The Gross Margin of Xbrane Biopharma AB (XBRANE.ST) is 90.83%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 90.83% |
| 2023-12-31 | 14.82% |
| 2022-12-31 | 22.35% |
| 2021-12-31 | 23.79% |
| 2020-12-31 | -1653.58% |